Last $14.72 USD
Change Today -0.24 / -1.60%
Volume 2.1M
DEPO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vicente Anido Jr., Ph.D.

Chairman of the Board and Chief Executive Officer, Aerie Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
61$8,172,545
As of Fiscal Year 2013

Background*

Dr. Vicente Anido, Jr., also known as Vince, Ph.D. has been the Chief Executive Officer of Aerie Pharmaceuticals, Inc. since July 26, 2013 and its Chairman of the Board since April 4, 2013. Dr. Anido served as the President and Chief Executive Officer of ISTA Pharmaceuticals, which was acquired by Bausch + Lomb Incorporated in June 2012. Prior to joining ISTA Pharmaceuticals as the President and Chief Executive Officer in 2000, Dr. Anido served as a General Partner of ...

Read Full Background

Corporate Headquarters*

7999 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-744-8000
Fax: 510-744-8001

Board Members Memberships*

2013-2014
Former Director
2013-Present
Independent Director and Member of Audit Committee
2013-Present
Chairman of the Board and Chief Executive Officer

Education*

PhD
University of Missouri-Columbia
MS
West Virginia University
BS
West Virginia University

Other Affiliations*

Annual Compensation*

Salary$205,309
Bonus$163,281
Total Annual Compensation$368,590

Stock Options*

All Other Compensation$40,000
Exercisable Options41,321
Exercisable Options Value$622,294
Unexercisable Options1,005,008
Unexercisable Options Value$14,904,803
Total Value of Options$15,527,097
Total Number of Options1,046,329

Total Compensation*

Total Annual Cash Compensation$408,590
Total Short Term Compensation$368,590
Other Long Term Compensation$40,000
Total Calculated Compensation$8,172,545
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DEPO:US $14.72 USD -0.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEPOMED INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.